Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNA.
Marret G, Lamy C, Vacher S, Cabel L, Séné M, Ahmanache L, Courtois L, El Beaino Z, Klijanienko J, Martinat C, Servant N, Kamoun C, Halladjian M, Bronzini T, Balsat C, Laes JF, Prévot A, Sauvage S, Lienard M, Martin E, Genin B, Badois N, Lesnik M, Dubray-Vautrin A, Choussy O, Ghanem W, Taouachi R, Planchon JM, Bièche I, Le Tourneau C, Kamal M. Marret G, et al. Among authors: laes jf. Oral Oncol. 2025 Jan;160:107111. doi: 10.1016/j.oraloncology.2024.107111. Epub 2024 Nov 29. Oral Oncol. 2025. PMID: 39612700
Hospital Provider's Perspectives on MOUD Initiation and Continuation After Inpatient Discharge.
Shearer R, Englander H, Hagedorn H, Fawole A, Laes J, Titus H, Patten A, Oot E, Appleton N, Fitzpatrick A, Kibben R, Fernando J, McNeely J, Gustafson D, Krawczyk N, Weinstein Z, Baukol P, Ghitza U, Siegler T, Bart G, Bazzi A. Shearer R, et al. Among authors: laes j. J Gen Intern Med. 2024 Nov 25. doi: 10.1007/s11606-024-09008-x. Online ahead of print. J Gen Intern Med. 2024. PMID: 39586949
Barriers and facilitators to implementing treatment for opioid use disorder in community hospitals.
Shearer R, Hagedorn H, Englander H, Siegler T, Kibben R, Fawole A, Patten A, Fitzpatrick A, Laes J, Fernando J, Appleton N, Oot E, Titus H, Krawczyk N, Weinstein Z, McNeely J, Baukol P, Ghitza U, Gustafson D, Bart G, Bazzi A. Shearer R, et al. Among authors: laes j. J Subst Use Addict Treat. 2024 Dec;167:209520. doi: 10.1016/j.josat.2024.209520. Epub 2024 Sep 10. J Subst Use Addict Treat. 2024. PMID: 39265915 Free article.
Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
Gombos A, Venet D, Ameye L, Vuylsteke P, Neven P, Richard V, Duhoux FP, Laes JF, Rothe F, Sotiriou C, Paesmans M, Awada A, Guiot T, Flamen P, Piccart-Gebhart M, Ignatiadis M, Gebhart G. Gombos A, et al. Among authors: laes jf. NPJ Breast Cancer. 2022 Mar 16;8(1):38. doi: 10.1038/s41523-022-00409-x. NPJ Breast Cancer. 2022. PMID: 35296682 Free PMC article. No abstract available.
FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
Gombos A, Venet D, Ameye L, Vuylsteke P, Neven P, Richard V, Duhoux FP, Laes JF, Rothe F, Sotiriou C, Paesmans M, Awada A, Guiot T, Flamen P, Piccart-Gebhart M, Ignatiadis M, Gebhart G. Gombos A, et al. Among authors: laes jf. NPJ Breast Cancer. 2021 Sep 21;7(1):125. doi: 10.1038/s41523-021-00331-8. NPJ Breast Cancer. 2021. PMID: 34548493 Free PMC article.
45 results